Evans DG*, Evans G*
Evans DG*, Evans G*
University of Manchester
Verifierad e-postadress på mft.nhs.uk
Titel
Citeras av
Citeras av
År
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
American journal of human genetics 72 (5), 1117, 2003
39132003
Genome-wide association study identifies novel breast cancer susceptibility loci
DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ...
Nature 447 (7148), 1087-1093, 2007
25482007
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ...
New England Journal of Medicine 346 (21), 1616-1622, 2002
16822002
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ...
Jama 304 (9), 967-975, 2010
12642010
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L van’t Veer, JE Garber, ...
Journal of Clinical Oncology 22 (6), 1055-1062, 2004
12402004
Low-penetrance susceptibility to breast cancer due to CHEK2* 1100delC in noncarriers of BRCA1 or BRCA2 mutations
H Meijers-Heijboer, A van den Ouweland, J Klijn, M Wasielewski, ...
Nature genetics 31 (1), 55-59, 2002
1211*2002
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
MO Leach, CR Boggis, AK Dixon, DF Easton, RA Eeles, DG Evans, ...
Lancet 365 (9473), 1769, 2005
11732005
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans, ME Baser, J McGaughran, S Sharif, E Howard, A Moran
Journal of medical genetics 39 (5), 311-314, 2002
10692002
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
SR Cairns, JH Scholefield, RJ Steele, MG Dunlop, HJW Thomas, ...
Gut 59 (5), 666-689, 2010
10332010
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ...
Nature genetics 45 (4), 353-361, 2013
10222013
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ...
Jama 317 (23), 2402-2416, 2017
9892017
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
N Rahman, S Seal, D Thompson, P Kelly, A Renwick, A Elliott, S Reid, ...
Nature genetics 39 (2), 165-167, 2007
9802007
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in …
SR Lakhani, MJ Van De Vijver, J Jacquemier, TJ Anderson, PP Osin, ...
Journal of clinical oncology 20 (9), 2310-2318, 2002
9472002
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ...
The Lancet 378 (9809), 2081-2087, 2011
9232011
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
RE Ferner, SM Huson, N Thomas, C Moss, H Willshaw, DG Evans, ...
Journal of medical genetics 44 (2), 81-88, 2007
8902007
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24. 21
I Tomlinson, E Webb, L Carvajal-Carmona, P Broderick, Z Kemp, S Spain, ...
Nature genetics 39 (8), 984-988, 2007
8602007
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
N Craddock, ME Hurles, N Cardin, RD Pearson, V Plagnol, S Robson, ...
Nature 464 (7289), 713, 2010
8272010
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
J Cuzick, JF Forbes, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, ...
The Lancet 360, 817-824, 2002
7952002
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, ...
Nature Genetics, 2012
7742012
Oral contraceptives and the risk of hereditary ovarian cancer
SA Narod, H Risch, R Moslehi, A Dørum, S Neuhausen, H Olsson, ...
New England Journal of Medicine 339 (7), 424-428, 1998
7701998
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20